These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18227856)

  • 1. Beyond prostate-specific antigen: alternate serum markers.
    Ramírez ML; Nelson EC; Evans CP
    Prostate Cancer Prostatic Dis; 2008; 11(3):216-29. PubMed ID: 18227856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers of prostate cancer.
    Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
    Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for prostate cancer detection.
    Parekh DJ; Ankerst DP; Troyer D; Srivastava S; Thompson IM
    J Urol; 2007 Dec; 178(6):2252-9. PubMed ID: 17936845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood biomarkers for prostate cancer detection and prognosis.
    Shariat SF; Karam JA; Roehrborn CG
    Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.
    van Gils MP; Stenman UH; Schalken JA; Schröder FH; Luider TM; Lilja H; Bjartell A; Hamdy FC; Pettersson KS; Bischoff R; Takalo H; Nilsson O; Mulders PF; Bangma CH
    Eur Urol; 2005 Dec; 48(6):1031-41. PubMed ID: 16054748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].
    Medvedev VL
    Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer biomarkers: knowing the present and predicting the future.
    Chatterjee SK; Zetter BR
    Future Oncol; 2005 Feb; 1(1):37-50. PubMed ID: 16555974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New circulating biomarkers for prostate cancer.
    Bensalah K; Lotan Y; Karam JA; Shariat SF
    Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Markers for diagnosis, prediction and prognosis of prostate cancer].
    Taskén KA; Angelsen A; Svindland A; Eide T; Berge V; Wahlquist R; Karlsen S
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3279-82. PubMed ID: 16327854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum markers for prostate cancer: a rational approach to the literature.
    Steuber T; O'Brien MF; Lilja H
    Eur Urol; 2008 Jul; 54(1):31-40. PubMed ID: 18243505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The density of prostate specific antigen of the transition zone as an early predictor of prostate cancer].
    Topuzov ME; Prialukhin AE; Zhivov AV; Plekhanov AIu
    Vestn Khir Im I I Grek; 2008; 167(6):119-21. PubMed ID: 19241832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of early-stage prostate carcinoma. Improved prognosis--fewer complications].
    Bastian PJ; Stief CG
    MMW Fortschr Med; 2010 May; 152(19):36. PubMed ID: 20556999
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.
    Shafer MW; Mangold L; Partin AW; Haab BB
    Prostate; 2007 Feb; 67(3):255-67. PubMed ID: 17192876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen.
    Fradet Y
    Curr Opin Urol; 2009 May; 19(3):243-6. PubMed ID: 19325493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are multiple markers the future of prostate cancer diagnostics?
    Mikolajczyk SD; Song Y; Wong JR; Matson RS; Rittenhouse HG
    Clin Biochem; 2004 Jul; 37(7):519-28. PubMed ID: 15234233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.
    Lin DW
    Urol Oncol; 2009; 27(3):315-21. PubMed ID: 19414121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.
    Bickers B; Aukim-Hastie C
    Anticancer Res; 2009 Aug; 29(8):3289-98. PubMed ID: 19661347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate specific antigen and other markers for prostate cancer.
    Schröder FH
    J Urol; 2006 Apr; 175(4):1199-200. PubMed ID: 16515959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.